In this report, we present the case of a female BRCA2 mutation carrier who was diagnosed with five different malignancies: two independent breast cancers, well-differentiated liposarcoma, clear cell renal cell carcinoma (ccRCC) and therapy-related myeloproliferative neoplasia. This evidence concerns the gene BRCA2 and breast carcinoma.